Johns Hopkins ABX Guide
Elbasvir/Grazoprevir
INDICATIONS
FDA
FDA
Treatment of hepatitis C infection (HCV) genotypes 1 or 4 in adults with or without ribavirin
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 1, 2017
Citation
Smith, Janessa M. "Elbasvir/Grazoprevir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540664/6/Elbasvir_Grazoprevir.
Smith JM. Elbasvir/Grazoprevir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540664/6/Elbasvir_Grazoprevir. Accessed December 26, 2024.
Smith, J. M. (2017). Elbasvir/Grazoprevir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540664/6/Elbasvir_Grazoprevir
Smith JM. Elbasvir/Grazoprevir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2024 December 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540664/6/Elbasvir_Grazoprevir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Elbasvir/Grazoprevir
ID - 540664
A1 - Smith,Janessa,Pharm.D. BCPS
Y1 - 2017/02/01/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540664/6/Elbasvir_Grazoprevir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
